Table of Contents Global API(Active Pharmaceutical Ingredient) Intermediate Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications 1 Study Coverage 1.1 API(Active Pharmaceutical Ingredient) Intermediate Product 1.2 Key Market Segments in This Study 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Type 1.4.2 Biotech Intermediates 1.4.3 Chemical Intermediates 1.5 Market by Application 1.5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Application 1.5.2 Oncology 1.5.3 Diabetes 1.5.4 Endocrinology 1.5.5 Cardiovascular Disease 1.5.6 CNS & Neurological Disorders 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production 2.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue 2014-2025 2.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production 2014-2025 2.1.3 Global API(Active Pharmaceutical Ingredient) Intermediate Capacity 2014-2025 2.1.4 Global API(Active Pharmaceutical Ingredient) Intermediate Marketing Pricing and Trends 2.2 API(Active Pharmaceutical Ingredient) Intermediate Growth Rate (CAGR) 2019-2025 2.3 Analysis of Competitive Landscape 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 2.3.2 Key API(Active Pharmaceutical Ingredient) Intermediate Manufacturers 2.4 Market Drivers, Trends and Issues 2.5 Macroscopic Indicator 2.5.1 GDP for Major Regions 2.5.2 Price of Raw Materials in Dollars: Evolution 3 Market Size by Manufacturers 3.1 API(Active Pharmaceutical Ingredient) Intermediate Production by Manufacturers 3.1.1 API(Active Pharmaceutical Ingredient) Intermediate Production by Manufacturers 3.1.2 API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Manufacturers 3.2 API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers 3.2.1 API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers (2014-2019) 3.2.2 API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2014-2019) 3.3 API(Active Pharmaceutical Ingredient) Intermediate Price by Manufacturers 3.4 Mergers & Acquisitions, Expansion Plans 4 API(Active Pharmaceutical Ingredient) Intermediate Production by Regions 4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production by Regions 4.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions 4.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions 4.2 United States 4.2.1 United States API(Active Pharmaceutical Ingredient) Intermediate Production 4.2.2 United States API(Active Pharmaceutical Ingredient) Intermediate Revenue 4.2.3 Key Players in United States 4.2.4 United States API(Active Pharmaceutical Ingredient) Intermediate Import & Export 4.3 Europe 4.3.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Production 4.3.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue 4.3.3 Key Players in Europe 4.3.4 Europe API(Active Pharmaceutical Ingredient) Intermediate Import & Export 4.4 China 4.4.1 China API(Active Pharmaceutical Ingredient) Intermediate Production 4.4.2 China API(Active Pharmaceutical Ingredient) Intermediate Revenue 4.4.3 Key Players in China 4.4.4 China API(Active Pharmaceutical Ingredient) Intermediate Import & Export 4.5 Japan 4.5.1 Japan API(Active Pharmaceutical Ingredient) Intermediate Production 4.5.2 Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue 4.5.3 Key Players in Japan 4.5.4 Japan API(Active Pharmaceutical Ingredient) Intermediate Import & Export 4.6 Other Regions 4.6.1 South Korea 4.6.2 India 4.6.3 Southeast Asia 5 API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions 5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions 5.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions 5.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions 5.2 North America 5.2.1 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application 5.2.2 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries 5.2.3 United States 5.2.4 Canada 5.2.5 Mexico 5.3 Europe 5.3.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application 5.3.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries 5.3.3 Germany 5.3.4 France 5.3.5 UK 5.3.6 Italy 5.3.7 Russia 5.4 Asia Pacific 5.4.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application 5.4.2 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries 5.4.3 China 5.4.4 Japan 5.4.5 South Korea 5.4.6 India 5.4.7 Australia 5.4.8 Indonesia 5.4.9 Thailand 5.4.10 Malaysia 5.4.11 Philippines 5.4.12 Vietnam 5.5 Central & South America 5.5.1 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application 5.5.2 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries 5.5.3 Brazil 5.6 Middle East and Africa 5.6.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application 5.6.2 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries 5.6.3 Turkey 5.6.4 GCC Countries 5.6.5 Egypt 5.6.6 South Africa 6 Market Size by Type 6.1 Global API(Active Pharmaceutical Ingredient) Intermediate Breakdown Dada by Type 6.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Type 6.3 API(Active Pharmaceutical Ingredient) Intermediate Price by Type 7 Market Size by Application 7.1 Overview 7.2 Global API(Active Pharmaceutical Ingredient) Intermediate Breakdown Dada by Application 7.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application 7.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2014-2019) 8 Manufacturers Profiles 8.1 Jigs Chemical 8.1.1 Jigs Chemical Company Details 8.1.2 Company Description 8.1.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.1.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.1.5 SWOT Analysis 8.2 Sanofi Winthrop Industrie S.A. 8.2.1 Sanofi Winthrop Industrie S.A. Company Details 8.2.2 Company Description 8.2.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.2.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.2.5 SWOT Analysis 8.3 Shandong Jiulong Fine Chemical Co., Ltd. 8.3.1 Shandong Jiulong Fine Chemical Co., Ltd. Company Details 8.3.2 Company Description 8.3.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.3.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.3.5 SWOT Analysis 8.4 Hipharma Limited 8.4.1 Hipharma Limited Company Details 8.4.2 Company Description 8.4.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.4.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.4.5 SWOT Analysis 8.5 AMPAC Fine Chemicals 8.5.1 AMPAC Fine Chemicals Company Details 8.5.2 Company Description 8.5.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.5.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.5.5 SWOT Analysis 8.6 BASF 8.6.1 BASF Company Details 8.6.2 Company Description 8.6.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.6.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.6.5 SWOT Analysis 8.7 Cambrex Corporation 8.7.1 Cambrex Corporation Company Details 8.7.2 Company Description 8.7.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.7.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.7.5 SWOT Analysis 8.8 A R Life Sciences Pvt. Ltd. 8.8.1 A R Life Sciences Pvt. Ltd. Company Details 8.8.2 Company Description 8.8.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.8.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.8.5 SWOT Analysis 8.9 Dragon Hwa ChemPharm. Co., Ltd. 8.9.1 Dragon Hwa ChemPharm. Co., Ltd. Company Details 8.9.2 Company Description 8.9.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.9.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.9.5 SWOT Analysis 8.10 Ami Life Sciences Pvt. Ltd. 8.10.1 Ami Life Sciences Pvt. Ltd. Company Details 8.10.2 Company Description 8.10.3 Capacity, Production and Value of API(Active Pharmaceutical Ingredient) Intermediate 8.10.4 API(Active Pharmaceutical Ingredient) Intermediate Product Description 8.10.5 SWOT Analysis 9 Production Forecasts 9.1 API(Active Pharmaceutical Ingredient) Intermediate Production and Revenue Forecast 9.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2019-2025 9.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 9.2 API(Active Pharmaceutical Ingredient) Intermediate Production and Revenue Forecast by Regions 9.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions 9.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Regions 9.3 API(Active Pharmaceutical Ingredient) Intermediate Key Producers Forecast 9.3.1 United States 9.3.2 Europe 9.3.3 China 9.3.4 Japan 9.4 Forecast by Type 9.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Type 9.4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type 10 Consumption Forecast 10.1 Consumption Forecast by Application 10.2 API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 10.3 North America Market Consumption Forecast 10.3.1 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2019-2025 10.3.2 United States 10.3.3 Canada 10.3.4 Mexico 10.4 Europe Market Consumption Forecast 10.4.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2019-2025 10.4.2 Germany 10.4.3 France 10.4.4 UK 10.4.5 Italy 10.4.6 Russia 10.5 Asia Pacific Market Consumption Forecast 10.5.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2019-2025 10.5.2 China 10.5.3 Japan 10.5.4 Korea 10.5.5 India 10.5.6 Australia 10.5.7 Indonesia 10.5.8 Thailand 10.5.9 Malaysia 10.5.10 Philippines 10.5.11 Vietnam 10.6 Central & South America Market Consumption Forecast 10.6.1 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Country 2019-2025 10.6.2 Brazil 10.7 Middle East and Africa Market Consumption Forecast 10.7.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Countries 2019-2025 10.7.2 Middle East and Africa 10.7.3 Turkey 10.7.4 GCC Countries 10.7.5 Egypt 10.7.6 South Africa 11 Upstream, Industry Chain and Downstream Customers Analysis 11.1 Analysis of API(Active Pharmaceutical Ingredient) Intermediate Upstream Market 11.1.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Material 11.1.2 Typical Suppliers of Key API(Active Pharmaceutical Ingredient) Intermediate Raw Material 11.1.3 API(Active Pharmaceutical Ingredient) Intermediate Raw Material Market Concentration Rate 11.2 API(Active Pharmaceutical Ingredient) Intermediate Industry Chain Analysis 11.3 Marketing & Distribution 11.4 API(Active Pharmaceutical Ingredient) Intermediate Distributors 11.5 API(Active Pharmaceutical Ingredient) Intermediate Customers 12 Opportunities & Challenges, Threat and Affecting Factors 12.1 Market Opportunities 12.2 Market Challenges 12.3 Porter's Five Forces Analysis 13 Key Findings 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables and Figures Figure API(Active Pharmaceutical Ingredient) Intermediate Product Picture Table API(Active Pharmaceutical Ingredient) Intermediate Key Market Segments in This Study Table Key Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Covered in This Study Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share 2014-2025 Figure Biotech Intermediates Product Picture Table Major Manufacturers of Biotech Intermediates Figure Chemical Intermediates Product Picture Table Major Manufacturers of Chemical Intermediates Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Application 2019-2025 (K MT) Figure Oncology Figure Diabetes Figure Endocrinology Figure Cardiovascular Disease Figure CNS & Neurological Disorders Figure API(Active Pharmaceutical Ingredient) Intermediate Report Years Considered Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue 2014-2025 (Million US$) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production 2014-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Capacity 2014-2025 (K MT) Table Key Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Capacity (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Price 2014-2025 (USD/MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Regions 2019-2025(K MT) & (Million US$) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution and Headquarters Table Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Product Offered Table Date of Manufacturers Enter into API(Active Pharmaceutical Ingredient) Intermediate Market Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Manufacturers (2014-2019) (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Manufacturers in 2018 Table API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers (2014-2019) (Million US$) Table API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2014-2019) Figure API(Active Pharmaceutical Ingredient) Intermediate Value Share by Manufacturers in 2018 Table API(Active Pharmaceutical Ingredient) Intermediate Price by Manufacturers 2014-2019 (USD/MT) Table Mergers & Acquisitions, Expansion Plans Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Regions 2014-2019 (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions 2014-2019 Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions 2014-2019 Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Regions in 2018 Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Regions 2014-2019 (Million US$) Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions 2014-2019 Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions 2014-2019 Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Regions in 2018 Figure United States API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2014-2019 (K MT) Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2014-2019 (Million US$) Table United States API(Active Pharmaceutical Ingredient) Intermediate Import & Export Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2014-2019 (K MT) Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2014-2019 (Million US$) Table Europe API(Active Pharmaceutical Ingredient) Intermediate Import & Export Figure China API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2014-2019 (K MT) Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2014-2019 (Million US$) Table China API(Active Pharmaceutical Ingredient) Intermediate Import & Export Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Production and Growth Rate 2014-2019 (K MT) Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue and Growth Rate 2014-2019 (Million US$) Table Japan API(Active Pharmaceutical Ingredient) Intermediate Import & Export Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Regions 2014-2019 (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions 2014-2019 Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions 2014-2019 Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Regions in 2018 Figure North America API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Table North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2019) (K MT) Figure 2018 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application Table North America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2014-2019) (K MT) Figure 2018 North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries Figure United States API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Canada API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) and Growth Rate (2014-2019) Figure Mexico API(Active Pharmaceutical Ingredient) Intermediate Consumption (K MT) and Growth Rate (2014-2019) Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Table Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2019) (K MT) Figure 2018 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application Table Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2014-2019) (K MT) Figure 2018 Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure France API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure UK API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2019) (K MT) Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2014-2019) (K MT) Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2014-2019) (K MT) Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries (2014-2019) (K MT) Figure China API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Korea API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure India API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Australia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Indonesia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Thailand API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Malaysia API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Philippines API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Vietnam API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (K MT) Table Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2019) (K MT) Figure 2017 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application Table Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2014-2019) (K MT) Figure Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries Figure Brazil API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (K MT) Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2019) (K MT) Figure 2018 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption by Countries (2014-2019) (K MT) Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Countries Figure Turkey API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure GCC Countries API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption and Growth Rate (2014-2019) (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Production by Type (2014-2019) (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Share by Type (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Type (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share by Type in 2018 Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Type (2014-2019) (Million US$) Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Type (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Type in 2018 Table API(Active Pharmaceutical Ingredient) Intermediate Price by Type 2014-2019 (USD/MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2025) (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption by Application (2014-2019) (K MT) Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Share by Application (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application (2014-2019) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Value (Consumption) Market Share by Application (2014-2019) Table Jigs Chemical Company Details Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table Sanofi Winthrop Industrie S.A. Company Details Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table Shandong Jiulong Fine Chemical Co., Ltd. Company Details Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table Hipharma Limited Company Details Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table AMPAC Fine Chemicals Company Details Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table BASF Company Details Table BASF API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure BASF API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table BASF API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table Cambrex Corporation Company Details Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table A R Life Sciences Pvt. Ltd. Company Details Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table Dragon Hwa ChemPharm. Co., Ltd. Company Details Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Table Ami Life Sciences Pvt. Ltd. Company Details Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019) Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Growth Rate (2014-2019) Figure Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Market Share in Global Market Table Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate SWOT Analysis Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 (Million US$) Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 (Million US$) Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions 2019-2025 (Million US$) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions 2019-2025 (Million US$) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Regions 2019-2025 Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Regions 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Regions 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share Forecast by Regions 2019-2025 Figure United States API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2019-2025 (K MT) Figure United States API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 (Million US$) Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2019-2025 (K MT) Figure Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 (Million US$) Figure China API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2019-2025 (K MT) Figure China API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 (Million US$) Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Production Forecast 2019-2025 (K MT) Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast 2019-2025 (Million US$) Table Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Type 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Forecast by Type 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Production Market Share Forecast by Type 2019-2025 Table Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type 2019-2025 (Million US$) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type 2019-2025 (Million US$) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Type 2019-2025 Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Application 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Application 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share Forecast by Application 2019-2025 Table Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share Forecast by Regions 2019-2025 Table North America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure United States API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Canada API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure MexicoAPI(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Table Europe API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure Germany API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure France API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure UK API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Italy API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Russia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Table Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure China API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Japan API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Korea API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure India API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Australia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Indonesia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Thailand API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Malaysia API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Philippines API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Vietnam API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Table Central & South America API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure Brazil API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Table Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast by Regions 2019-2025 (K MT) Figure Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Turkey API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure GCC Countries API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure Egypt API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Figure South Africa API(Active Pharmaceutical Ingredient) Intermediate Consumption Forecast 2019-2025 (K MT) Table API(Active Pharmaceutical Ingredient) Intermediate Key Raw Material Table Typical Suppliers of Key API(Active Pharmaceutical Ingredient) Intermediate Raw Material Figure API(Active Pharmaceutical Ingredient) Intermediate Industry Chain Table Distributors/Traders List Table API(Active Pharmaceutical Ingredient) Intermediate Customers List Table Porter’s Five Forces Analysis Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Jigs Chemical Sanofi Winthrop Industrie S.A. Shandong Jiulong Fine Chemical Co., Ltd. Hipharma Limited AMPAC Fine Chemicals BASF Cambrex Corporation A R Life Sciences Pvt. Ltd. Dragon Hwa ChemPharm. Co., Ltd. Ami Life Sciences Pvt. Ltd.